A placebo-controlled trial of thymic hormone treatment of recurrent herpes simplex labialis infection in immunodeficient host: Results after a 1-year follow-up
- 1 January 1984
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 30 (1) , 11-18
- https://doi.org/10.1016/0090-1229(84)90002-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- In vitro induction of human cell-mediated cytotoxicity directed against herpes simplex virus-infected cells: characterization of the effector lymphocyte.The Journal of Immunology, 1980
- Thymic hormonal activity on human peripheral blood lymphocytes in vitro. II. Enhancement of the production of immune interferon by activated cells.The Journal of Immunology, 1980
- In vitro and in vivo responses to thymosin in severe combined immunodeficiencyClinical Immunology and Immunopathology, 1979
- The Mechanism of Recurrent Infection by Herpesvirus hominisArchives of Dermatology, 1976
- Cellular Immune Responses to Herpes Simplex Virus Type 1 in Recurrent Herpes Labialis: In Vitro Blastogenesis and Cytotoxicity to Infected Cell LinesThe Journal of Infectious Diseases, 1975
- Infection with Herpes-Simplex Viruses 1 and 2New England Journal of Medicine, 1973
- SURFACE MARKERS ON HUMAN T AND B LYMPHOCYTESThe Journal of Experimental Medicine, 1972
- Intraoral lesions of adults associated with herpes simplex virusOral Surgery, Oral Medicine, Oral Pathology, 1971
- HERPES-SIMPLEX-VIRUS INFECTION AFTER RENAL TRANSPLANTATIONThe Lancet, 1969
- Rapid Diagnosis of Herpesvirus Hominis Infections in Superficial Lesions by Immunofluorescent Antibody TechniquesBMJ, 1968